For millions of Americans who struggle with sleep apnea, using a CPAP machine might feel like an inconvenience — the mask ...

You don’t have to run in biohacking circles to have noticed that red light therapy is having a moment. You could just go to the mall. Previously the domain of private medspas and bleeding-edge ...

Twenty-eight years later, as a political science professor emeritus at Stanford, Krehbiel just became the first person in the ...

Parkinson's Patients Have Improved Motor and Non-Motor Function After Treatment with Theralase(R) Cool Laser TherapyToronto, ...

Patients' own stem cells to replace damaged dopamine cells in Parkinson’s disease, offering new hope. Parkinson's disease - ...

Mar. 9, 2025 — A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells ...

A CU Anschutz patient made a bit of history Friday as the first person in the nation with Parkinson's disease to experience ... a new system that adjusts the therapy to “individual brain activit ...

Professor Karlo Malaga leads research focusing on pinpointing specific areas in the subthalamic region where deep brain ...

In a real-world clinical study published last year, data showed that by reading activity in the areas of the brain linked with Parkinson’s ... therapy. And like in Europe, the FDA’s green ...

MeiraGTx has one gene therapy in a potentially pivotal clinical trial for cancer patients and another gene therapy ready to start Phase 3 in Parkinson’s disease. Completing the studies will be ...

Artificial intelligence company Hologen AI has committed up to $430 million as part of a multifaceted agreement to help take MeiraGTx’s Parkinson’s disease gene therapy all the way to market.

is pleased to announce that interim clinical data for patients diagnosed with Parkinson's Disease ("PD") and treated with the Theralase® TLC-2400 Cool Laser Therapy ("CLT") system have improved ...